Select a relevant service

Run market feasibility studies, establish customer needs, improve product performance and analyze competition.

Studies (prospective or retrospective) utilizing data obtained from "real world settings" , and is outside the tight controls of a clinical trial design.

Summarizes the results of research (that meet pre-defined eligibility criteria for inclusion) and provides a high level of evidence on the outcomes assessed.

Request consulting services related to small molecule development.

Develop value story tailored to a payer audience that will determine the appropriate price for treatment.

The generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care.

Design phase 1-3 studies that seek to identify if a drug is safe, effective, and more efficient than other available treatments on the market.

Analyze risks and opportunities in new markets and ensure patients have timely and continued access to new treatments.

Plan and strategy of the data collection and information throughout the different phases of product development (portfolio assessment, pre-clinical trials, clinical trials, pre-authorization, post-authorization, and RWE)

Manage a portfolio of projects in early-stage drug discovery and provide factors that determine the success of the proposed portfolio.